Who’s In and Out on Trump’s Health Team, BMS Cedes Ground to Merck, & CRE Superbugs on the Move

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.